Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation
about
A Novel Xenomonitoring Technique Using Mosquito Excreta/Feces for the Detection of Filarial Parasites and MalariaMolecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American SamoaElimination of lymphatic filariasis in the GambiaA comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administrationSeroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administrationCessation of mass drug administration for lymphatic filariasis in Zanzibar in 2006: was transmission interrupted?Improving Coverage and Compliance in Mass Drug Administration for the Elimination of LF in Two 'Endgame' Districts in Indonesia Using Micronarrative SurveysControlling Neglected Tropical Diseases (NTDs) in Haiti: Implementation Strategies and Evidence of Their SuccessNeglected tropical diseases in the genomics era: re-evaluating the impact of new drugs and mass drug administrationGlobal programme to eliminate lymphatic filariasis: the processes underlying programme success.Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.Application of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.Detecting infection hotspots: Modeling the surveillance challenge for elimination of lymphatic filariasis.Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu.First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards eliminationThe global distribution and transmission limits of lymphatic filariasis: past and present.Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration.Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination programThe significant scale up and success of Transmission Assessment Surveys 'TAS' for endgame surveillance of lymphatic filariasis in Bangladesh: One step closer to the elimination goal of 2020Costs of Transmission Assessment Surveys to Provide Evidence for the Elimination of Lymphatic Filariasis.Presence of Wuchereria bancrofti microfilaremia despite 7 years of annual ivermectin monotherapy mass drug administration for onchocerciasis control: a study in north-west EthiopiaMathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.Impact of mass drug administration for elimination of lymphatic filariasis in NepalProspects, drawbacks and future needs of xenomonitoring for the endpoint evaluation of lymphatic filariasis elimination programs in Africa.Prevalence and risk factors associated with lymphatic filariasis in American Samoa after mass drug administration.Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration.The rationale and cost-effectiveness of a confirmatory mapping tool for lymphatic filariasis: Examples from Ethiopia and Tanzania.Defining Persistent Hotspots: Areas That Fail to Decrease Meaningfully in Prevalence after Multiple Years of Mass Drug Administration with Praziquantel for Control of Schistosomiasis.Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda.Economic evaluations of mass drug administration: The importance of economies of scale and scope.Rethinking the serological threshold for onchocerciasis elimination.Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016A superhydrophobic cone to facilitate the xenomonitoring of filarial parasites, malaria, and trypanosomes using mosquito excreta/fecesLymphatic Filariasis in Oceania
P2860
Q24288741-AAC8C68C-2D6B-4696-B80D-D94EB737FA24Q28541935-4C56E712-D7BE-4AAE-81DF-874C2BFA79B4Q28544640-6F481A07-18D8-4F75-ABE4-22E406E61949Q28544914-179D069E-2A9C-455A-A089-37061B369226Q28544925-E3286EBA-B1E1-440A-83D3-12B731744E88Q28545122-03732C9E-C699-4CAA-AF9B-70BD206DF38EQ28553208-BBF83CBB-9F4F-42F5-9EFB-B9FC72752B43Q28554503-13C41227-0C6E-43AC-8BFA-27FCBE5AB65AQ28602660-99C9800A-93C6-41B3-9F9F-AB74D2B01192Q30389980-0897EFE9-6314-45CB-80DB-637641477650Q30670492-4117A848-807F-4419-8949-EFAB87AC28BBQ33602799-209F4B1C-3D4E-4007-9EF5-D640624D31CCQ33752085-05DB8621-47E1-4FAE-882F-40704D6769EFQ33805156-5ED98751-904C-4636-89E4-EDC5D7D3E0ACQ33852823-0E0F0657-05A5-4BF8-83C1-F8515F24CE44Q34340088-8E1D829D-1440-4654-B3E9-1E6D5F3D6237Q34517923-39DCB838-04CA-4479-8F2E-1DC7B33895B2Q35795540-6CDD3062-58D0-4950-B9CE-73D7A4ACB0EAQ36264896-6D57ABC6-D18D-472D-AB3C-F349CF4C5179Q36266328-8067B2D0-2875-484D-BFAF-750302D7289BQ36622829-12578711-ECE6-43DD-BA3A-2A9A0E8FAD7DQ37254795-CB0250E4-0540-41E4-928E-7B5E31E84980Q38671914-D3752DB9-A2CF-421B-91B4-0FC7A4CE55C9Q38715445-7FDE2418-EFBE-40E6-9EE6-AB6D082A96A4Q38955116-BD148489-5627-4B14-848F-57C1878FB34EQ39331840-9E7C3BCD-40CE-46A7-A6D6-58E6A2D3F4E7Q42366319-C21D8CDD-C861-473B-B514-F7D8D2D0A6CBQ42695850-D622D700-77D8-40DA-BB85-73451C3DA94BQ43924383-AC3CE199-C14C-4153-8C0D-FA1DE00919D5Q44169405-C3A66441-BEA0-4422-A0C3-A081AF64C2F4Q46390703-E3BA1E98-A59C-46ED-AA0B-86345141E965Q47612597-5D958DFC-9CF0-4FA4-910C-A8648BA1312DQ55209417-057AEF30-4F41-4FBF-BA43-48E57D91B132Q56363362-914F924D-8951-4464-AED8-E4B4BDADE183Q56422088-E46A7B23-7906-4112-BE54-ABD5E50FF8B7Q57043705-C56F2C80-A302-4BB0-B1B5-1D00093A8979
P2860
Transmission assessment surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: a multicenter evaluation
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Transmission assessment survey ...... tion: a multicenter evaluation
@ast
Transmission assessment survey ...... tion: a multicenter evaluation
@en
Transmission assessment survey ...... tion: a multicenter evaluation
@nl
type
label
Transmission assessment survey ...... tion: a multicenter evaluation
@ast
Transmission assessment survey ...... tion: a multicenter evaluation
@en
Transmission assessment survey ...... tion: a multicenter evaluation
@nl
prefLabel
Transmission assessment survey ...... tion: a multicenter evaluation
@ast
Transmission assessment survey ...... tion: a multicenter evaluation
@en
Transmission assessment survey ...... tion: a multicenter evaluation
@nl
P2093
P2860
P50
P921
P3181
P1476
Transmission assessment survey ...... tion: a multicenter evaluation
@en
P2093
Alexandre Pavluck
Améyo M Dorkenoo
Brian K Chu
Dilhani Samarasekera
Dominique Kyelem
Eric A Ottesen
Fasihah Taleo
Gary J Weil
Irene Offei Owusu
Katherine Gass
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0002584
P407
P5008
P577
2013-01-01T00:00:00Z